parkinson's Flashcards
what are some risk factors for parkinson’s disease (PD)
rural living
well water
pesticides
heavy metal exposure
fungus (mushroom alcohol)
what are some protective risk factors for parkinson’s disease
cigarette smoking
caffeine consumption
describe the pathophysiology of PD
decreased dopamine in the brain (SUBSTANTIA NIGRA)
symptoms appear when 70-80% of SN neurons are depleted
what are the roles of dopamine in the brain?
smooth, controlled muscle movement
cognition and frontal cortex function
pleasure and motivation
what acronym describes the cardinal symptoms of PD?
TRAP:
Tremor
Rigidity
Akinesia/bradykinesia
Postural instability
the onset of cardinal signs in PD is usually _____ and ______
unilateral and asymmetric!!
describe the tremor in PD
usually occurs at rest and disappears with voluntary movement or sleep
initially affects upper extremities
can manifest as pill rolling
describe rigidity in PD
manifests as cogwheeling or hypomimia (blank face)
describe akinesia/bradykinesia in PD
slow throughout an intended action, difficulty initiating movement, microglia (letters get smaller as you write), shuffling, freezing
what may be some differential diagnoses to rule out for PD?
insult: TBI, stroke, pugilism, supranuclear palsy
infection: encephalitis, meningitis, HIV/AIDS
intoxication: carbon monoxide, mercury, Wilson’s disease (copper accumulation), drugs
which drugs may induce parkinsonian symptoms
antipsychotics except clozapine
antiemetics like prochlorperazine
methyldopa
anesthesia
opioid overdose
MPTP (contaminant in street drugs)
how can dopamine cross the blood brain barrier?
peripherally administered dopamine CANNOT cross the BBB (it is hydrophilic and there is no DA transporter)
but L-DOPA, the immediate precursor, can cross
why is carbidopa added to L-dopa
to block the decarboxylation of L-dopa to dopamine in the periphery so it can cross into the brain as L-DOPA
what is the gold standard drug for symptomatic PD initial therapy if rigidity or bradykinesia is the chief complain
L-DOPA/carbidopa
which age group is L-DOPA preferred
older adults 65+
safest side effect profile
younger patients report L-DOPA dyskinesias
how long is L-DOPA effective for?
a finite period of time ~10-15 years
how to convert to controlled release/extended release L-DOPA
increase the IR dose by 30%
dosing for L-dopa/carbidopa
initial 25 mg/100 mg daily: start low and go slow- increase by 1 tablet every other day– max dose determined by patient tolerability (~1500 mg/day). after IR stable, can switch to long acting
likely need at least _____ of carbidopa to adequately inhibit peripheral conversion of L-DOPA and prevent nausea/vomiting
75 mg/day
what are the adverse effects of L-DOPA
nausea/vomiting
postural hypotension
dyskinesias, psychiatric disturbances
patient counseling for L-DOPA/carbidopa
IR onset of action may take up to 1 hr; longer for CR
ER: do not crush, can open and sprinkle on applesauce
L-DOPA competes with protein for absorption: counsel on diet
must taper when discontinuing
when are DA agonists the preferred agent
in younger patients (can cause psychiatric disturbance in older patients) as initial therapy option if rigidity or bradykinesia is chief complaint
may be considered early monotherapy in L-DOPA sparing strategy